Influencing the inflammatory response of haemodialysis patients by cytokine elimination using large-pore membranes

Nephrology Dialysis Transplantation

Volumn 17, Issue 1, 2002, Pages 17-19

  Schindler, Ralf ^a,b   Senf, Raimund ^a   Frei, Ulrich ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

C reactive protein; Cardiovascular risk; Inflammatory mediators

Indexed keywords

BIOMATERIAL; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CYTOKINE PRODUCTION; DIALYSATE; DIALYSIS MEMBRANE; DISEASE SEVERITY; EXCRETION; EXTRACORPOREAL CIRCULATION; GLOMERULUS FILTRATION RATE; HALF LIFE TIME; HEART INFARCTION; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYDROPHILICITY; IMMUNOPATHOGENESIS; INFLAMMATION; KIDNEY CLEARANCE; KIDNEY FAILURE; MEDIATOR RELEASE; MEMBRANE PERMEABILITY; MONOCYTE; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VASCULAR ACCESS;

EID: 0036150114     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.1.17     Document Type: Article

References (23)

1. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
2. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
3. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
4. Production of C-reactive protein and risk of coronary events in stable and unstable angina
5. Atherosclerosis-an inflammatory disease
6. Premature cardiovascular disease in chronic renal failure
7. Elevated serum levels of C-reactive protein in hemodialysis patients
8. Elevated circulating levels of interleukin-6 in patients with chronic renal failure
9. Interleukin-6 predicts hypoalbuminemia hypocholesterolemia and mortality in hemodialysis patients
10. Inflammation enhances cardiovascular risk and mortality in hemodialysis
11. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy
12. Balance between IL-1 beta, TNF-alpha and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes
13. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration
14. Cytokines clearance during venovenous hemofiltration in the trauma patient
15. Cytokine removal during continuous hemofiltration in septic patients
16. Fate of injected interleukin 1 in rats: Sequestration and degradation in the kidney
17. Tissue localization and fate in mice of injected multipotential colony-stimulating factor
18. Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function
19. Transport mechanisms of cytokines through different dialyzers in vitro
20. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients
21. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments
22. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS dialysis morbidity and mortality study
23. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction